Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and tolerability of Andecaliximab as monotherapy and in combination with chemotherapy in advanced solid tumors completed, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Esophagogastric Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• Andecaliximab

Snippet

Sponsor: Gilead Sciences | Conditions: Pancreatic Cancer, Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2020-05-04